06.24.24 -- Accelerate Your Oligonucleotide Development And Scale-Up Goals

GenVoy-ILM, a pre-optimized lipid mixture designed to encapsulate RNA in LNP, is an effective tool for developing RNA medicines and can be used throughout drug development.

Discover the platform for oligonucleotide development and scale-up that is the result of 30 years of collaboration with leading oligonucleotide pharma. Explore this solution's benefits, specifications, and more.

Discover aseptic sampling solutions to seamlessly integrate with stainless steel processes and collect perfectly representative samples at every process step without false positives.

Explore a solution for biopharmaceutical companies concerned about the risks an increase in campaign volume can pose to their production timeline.

Explore a comprehensive chemical portfolio and make use of the raw materials required for mRNA with an integrated offering for all process steps, from plasmid DNA (pDNA) to mRNA synthesis to final formulation.

Discover how revolutionary and environmentally sustainable nanoparticle technologies coupled with innovative formulation approaches can address drug solubility issues and add value.

Gain insight into how you can de-risk mRNA regulatory approvals with critical quality attribute characterization and lot release testing.